Akosua Mireku

At the Outsourcing in Clinical Trials conference in New England, Andarix Pharmaceuticals’ CEO shared the uses of social media for improved rare disease trial patient recruitment. Credit: Kenneth Cheung via Getty Images. Social media has become an excellent tool for […]

As AI makes clinical operations more streamlined, companies will have to adapt their workforces to the new technology, say experts at the Outsourcing in Clinical Trials conference. sanjeri via Getty Images. As artificial intelligence (AI) permeates clinical trial operations more

ImmunoPrecise Antibodies’ CEO highlighted a growing trend in rabbit monoclonal antibody platform therapeutics, detailing the benefits of the modality. Credit: Richard Constantinoff via Getty Images. There is rising traction surrounding the development of rabbit monoclonal antibodies for cancer treatment, says

Sources from WuXi Biologics and WuXi Apptec say the companies are considering selling some of their operations as the Biosecure act moves through the US government. Credit: narvikk via Getty Images WuXi Biologics and WuXi AppTec are discussing the potential

The European Commission has approved Johnson and Johnson’s Yuvanci for pulmonary arterial hypertension, offering the first single-pill treatment option to European patients. Credit: andreswd via Getty Images. The European Commission (EC) has approved Johnson and Johnson’s Yuvanci (macitentan + tadalafil)

Iterum Therapeutics’s urinary tract infection antibiotic, oral sulopenem, is facing an FDA approval decision ahead of its 25 October PDUFA date. Credit: boonchai wedmakawand via Getty Images As antibiotic resistance continues to rise globally, reviewers at a recent FDA meeting